23andMe announces layoffs totaling 40% of workforce, discontinues therapeutics division
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
What 23andMe business troubles could mean for millions of users' genetic data
No. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered commercial, not medical. Because 23andMe is not a medical company, customers' ...
NBC Los Angeles1d
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Shares were hovering below $1 until 23andMe announced a 1-for-20 reverse stock split in October. In September, all seven of ...
Hosted on MSN1d
23andMe Lays Off 40% of Staff, Shuts Drug Development Business
DNA-testing company 23andMe said on Monday that it was firing roughly ... The company announced two weeks ago that it had ...
23andMe appoints three former CFOs as new directors—after the previous board all resigned
On Tuesday, Wojcicki announced the new additions to 23andMe’s board: Andre Fernandez, a former CFO at WeWork, Inc., and NCR ...
cfodive13d
23andMe turns to CFOs to fill director roles after mass board exit
Genetic testing company 23andMe has appointed three new independent directors to its board, including former WeWork CFO Andre ...
Benzinga.com1d
Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs
In September, independent directors of the Board of 23andMe sent a letter to Anne Wojcicki, Chief Executive Officer, Co ...
23andMe reports sales decline day after announcing plans to cut 40% of workforce
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
BBC on MSN1d
DNA-testing site 23andMe to lay off 40% of its workers
In another blow to the company, seven of 23andMe’s eight-strong board resigned in September. The firm's independent ...